178 related articles for article (PubMed ID: 33402488)
1. The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis.
Giannis D; Morsy S; Geropoulos G; Esagian SM; Sioutas GS; Moris D
In Vivo; 2021; 35(1):393-399. PubMed ID: 33402488
[TBL] [Abstract][Full Text] [Related]
2. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
[TBL] [Abstract][Full Text] [Related]
3. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
[TBL] [Abstract][Full Text] [Related]
4. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis.
Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
Cancer; 2019 Nov; 125(21):3767-3775. PubMed ID: 31299092
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results study.
Kokabi N; Xing M; Duszak R; Duszak R; Howard DH; Applegate KE; Camacho JC; Kim HS
Future Oncol; 2016 Jan; 12(2):183-98. PubMed ID: 26690268
[TBL] [Abstract][Full Text] [Related]
7. [Validation and modification of AJCC 8th edition staging system for hepatocellular carcinoma--analysis based on SEER database].
Wei YZ; Huang YQ; Zeng SY; Cai ZB; Peng YH; Zhu CL; Yu WL; Zhou YM
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2216-2222. PubMed ID: 34333934
[No Abstract] [Full Text] [Related]
8. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
[TBL] [Abstract][Full Text] [Related]
9. A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
Zhang K; Tao C; Wu F; Wu J; Rong W
Ann Palliat Med; 2021 Apr; 10(4):3847-3863. PubMed ID: 33752423
[TBL] [Abstract][Full Text] [Related]
10. Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma.
Li M; Wu L; Luo S; Liu Y; Sun C; Li E; Wang J; Li B; Huang Z; Ge J; Lei J; Zhou F; Liao W
Eur J Surg Oncol; 2023 Jul; 49(7):1217-1225. PubMed ID: 36690533
[TBL] [Abstract][Full Text] [Related]
11. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
[TBL] [Abstract][Full Text] [Related]
12. The power of tumor sizes in predicting the survival of solitary hepatocellular carcinoma patients.
Yang A; Xiao W; Chen D; Wei X; Huang S; Lin Y; Zhang C; Lin J; Deng F; Wu C; He X
Cancer Med; 2018 Dec; 7(12):6040-6050. PubMed ID: 30430769
[TBL] [Abstract][Full Text] [Related]
13. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
14. Selection of treatment modalities for hepatocellular carcinoma at stages T1 and T2: A preliminary analysis based on the Surveillance, Epidemiology, and End Results registry database.
Han B; Yao H; Shao L; Guo X; Han L; Gomes Romeiro F; Mancuso A; Qi X
J BUON; 2018; 23(3):611-621. PubMed ID: 30003727
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
[TBL] [Abstract][Full Text] [Related]
16. The growth rate of hepatocellular carcinoma is different with different TNM stages at diagnosis.
Gao TM; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):330-336. PubMed ID: 33637452
[TBL] [Abstract][Full Text] [Related]
17. Effect of marital status on the survival of patients with hepatocellular carcinoma treated with surgical resection: an analysis of 13,408 patients in the surveillance, epidemiology, and end results (SEER) database.
Wu C; Chen P; Qian JJ; Jin SJ; Yao J; Wang XD; Bai DS; Jiang GQ
Oncotarget; 2016 Nov; 7(48):79442-79452. PubMed ID: 27769053
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the discriminating value of the 8th AJCC stage grouping for hepatocellular carcinoma.
Abdel-Rahman O
HPB (Oxford); 2018 Jan; 20(1):41-48. PubMed ID: 28882455
[TBL] [Abstract][Full Text] [Related]
19. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
